Targeted News Service

Investigational gene therapy trial for rare kidney disease begins clinical trial at UAB
March 17, 2026

BIRMINGHAM, Alabama, March 17 -- The University of Alabama issued the following news:

* * *

Investigational gene therapy trial for rare kidney disease begins clinical trial at UAB

*

Eric Wallace, M.D. The University of Alabama at Birmingham is taking part in a groundbreaking Phase I/II clinical trial testing a one-time, intravenous investigational gene therapy that could transform care for patients with classic Fabry disease.

Fabr . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form